Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1223 Neoplasms 1028 Carcinoma, Non-Small-Cell Lung 747 Prostatic Neoplasms 693 Colorectal Neoplasms 591 Lung Neoplasms 576 Leukemia, Myeloid, Acute 396 Pancreatic Neoplasms 395 Neoplasm Metastasis 389 Ovarian Neoplasms 369 Multiple Myeloma 369 Stomach Neoplasms 318 Carcinoma, Hepatocellular 303 Melanoma 283 Brain Neoplasms 281 Recurrence 274 Squamous Cell Carcinoma of Head and Neck 266 Head and Neck Neoplasms 239 Glioblastoma 235 Endometrial Neoplasms 232 Triple Negative Breast Neoplasms 230 Lymphoma 223 Precursor Cell Lymphoblastic Leukemia-Lymphoma 222 Uterine Cervical Neoplasms 221 Sarcoma 202 Hematologic Neoplasms 202 Urinary Bladder Neoplasms 198 Esophageal Neoplasms 190 Carcinoma, Renal Cell 188 Lymphoma, Non-Hodgkin 176

Interventions

Darbepoetin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Primary Care × 1 year × Clear all

NCT07130487 2025-11-25

Project CARE: CAncer Risk Evaluation

Rutgers, The State University of New Jersey

Phase NA Recruiting

Primary Care

Data powered by HemOnc (CC BY 4.0) Colophon ⚡